Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q3 2023 Oncology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q3 2023 Oncology Update

Three transactions closed in Q3-23, representing a decrease from the prior quarter, and bringing the year-to-date total to 11.

The most notable transaction is American Oncology Network’s (AONC) SPAC transaction with Digital Transformation Opportunities Corp (DTOC). AONC delivers high-quality patient care across 75 clinics with a fully integrated service line including a specialty pharmacy, lab and pathology, radiation therapy, and imaging. The business combination with DTOC, along with a growth equity investment from AEA Growth, will help AONC unlock future growth initiatives and better serve its patients nationwide. As it currently stands, retail investors hold approximately 74% of AONC, with the remaining shares held by institutions and individual investors. On September 21st, shares began trading at approximately $20/share, but today the shares trade in the $6-$7/share range, implying retail investors will hold

To print and download the full Oncology Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Oncology.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]